Evidence map›Paper›PMID 36636055›Full record

ArticleJournal of gastrointestinal oncology2022

A study of gene variation in All-

Huimin Tao, Meng Shen, Xiaochang Zhang, Minghui Wang, Yan Wu, Hui Sun, Chen Ling, Ying Yang, Kai Chen, Dapeng Li

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of gastrointestinal oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Huimin TaoDepartment of Oncology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Meng ShenDepartment of Oncology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Xiaochang ZhangDepartment of Oncology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Minghui WangDepartment of Oncology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Yan WuDepartment of Oncology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Hui SunDepartment of Oncology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Chen LingDepartment of Oncology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Ying YangDepartment of Oncology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Kai ChenDepartment of Oncology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Dapeng LiDepartment of Oncology, The First Affiliated Hospital of Soochow University, Suzhou, China.
First Affiliated Hospital of Soochow University · CNSoochow University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: This study sought to explore the biological significance of genetic variation in Methods: A retrospective analysis of the data of 60 patients with stage IV mCRC who received cetuximab at The First and Second Affiliated Hospital of Soochow University from 2016 to 2020 was conducted. The patients were divided into the following 3 groups according to the genetic test results: (I) group A (the all- Results: The all- Conclusions: The PFS and OS of mCRC patients with all-

Indexed as

cetuximabgene alterationMetastatic colorectal cancer (mCRC)prognosissecond-generation sequencing

Identifiers

PMID36636055
PMCPMC9830345
OpenAlexW4313416402

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.